Exane Derivatives’s Thor Industries THO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,983
Closed -$235K 928
2022
Q1
$235K Buy
+2,983
New +$274K 0.07% 294
2021
Q4
Sell
-2,642
Closed -$324K 978
2021
Q3
$324K Buy
2,642
+584
+28% +$66.7K 0.08% 264
2021
Q2
$222K Buy
2,058
+1,085
+112% +$138K 0.05% 370
2021
Q1
$131K Buy
973
+969
+24,225% +$118K 0.04% 369
2020
Q4
$372 Sell
4
-62
-94% -$5.81K ﹤0.01% 761
2020
Q3
$6.29K Hold
66
﹤0.01% 491
2020
Q2
$7.03K Hold
66
﹤0.01% 432
2020
Q1
$2.78K Hold
66
﹤0.01% 481
2019
Q4
$5.33K Sell
66
-1,243
-95% -$80.2K ﹤0.01% 433
2019
Q3
$74.1K Hold
1,309
0.01% 342
2019
Q2
$76.5K Sell
1,309
-94
-7% -$5.7K 0.01% 359
2019
Q1
$87.5K Buy
1,403
+767
+121% +$48.6K 0.02% 310
2018
Q4
$33.1K Buy
+636
New +$43.1K 0.01% 405
2017
Q3
Sell
-1
Closed -$104 643
2017
Q2
$104 Hold
1
﹤0.01% 565
2017
Q1
$96 Hold
1
﹤0.01% 496
2016
Q4
$100 Hold
1
﹤0.01% 543
2016
Q3
$85 Hold
1
﹤0.01% 540
2016
Q2
$65 Hold
1
﹤0.01% 483
2016
Q1
$64 Buy
+1
New +$55 ﹤0.01% 544

Other funds holding THO

Exane Derivatives's THO Position: Q2 2022 in Review

Exane Derivatives sold out of Thor Industries (THO) in Q2 2022, closing a stake of 2,983 shares — an estimated $235K sold.

Exane Derivatives first reported a position in THO in Q1 2016 and held it in 19 quarters. The position peaked at $324K in Q3 2021. 421 funds tracked by Wall St. Rank hold THO as of Q2 2022.

  • Exane Derivatives reported no remaining Thor Industries position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 2,983 Thor Industries shares in Q2 2022, an estimated $235K.
  • Exane Derivatives first reported a position in Thor Industries in Q1 2016 and held it in 19 quarters.
  • Exane Derivatives's Thor Industries position peaked at $324K in Q3 2021.
  • 421 funds tracked by Wall St. Rank held Thor Industries as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.